Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Phelan R, Im A, Hunter RL, Inamoto Y, Lupo-Stanghellini MT, Rovo A, Badawy SM, Burns L, Eissa H, Murthy HS, Prasad P, Sharma A, Suelzer E, Agrawal V, Aljurf M, Baker K, Basak GW, Buchbinder D, DeFilipp Z, Grkovic LD, Dias A, Einsele H, Eisenberg ML, Epperla N, Farhadfar N, Flatau A, Gale RP, Greinix H, Hamilton BK, Hashmi S, Hematti P, Jamani K, Maharaj D, Murray J, Naik S, Nathan S, Pavletic S, Peric Z, Pulanic D, Ross R, Salonia A, Sanchez-Ortega I, Savani BN, Schechter T, Shah AJ, Smith SM, Snowden JA, Steinberg A, Tremblay D, Vij SC, Walker L, Wolff D, Yared JA, Schoemans H, Tichelli A. Phelan R, et al. Among authors: jamani k. Transplant Cell Ther. 2022 Jun;28(6):335.e1-335.e17. doi: 10.1016/j.jtct.2021.10.013. Epub 2021 Oct 29. Transplant Cell Ther. 2022. PMID: 34757220 Free PMC article.
Improved survival after acute graft-versus-host disease diagnosis in the modern era.
Khoury HJ, Wang T, Hemmer MT, Couriel D, Alousi A, Cutler C, Aljurf M, Antin JH, Ayas M, Battiwalla M, Cahn JY, Cairo M, Chen YB, Gale RP, Hashmi S, Hayashi RJ, Jagasia M, Juckett M, Kamble RT, Kharfan-Dabaja M, Litzow M, Majhail N, Miller A, Nishihori T, Qayed M, Schoemans H, Schouten HC, Socie G, Storek J, Verdonck L, Vij R, Wood WA, Yu L, Martino R, Carabasi M, Dandoy C, Gergis U, Hematti P, Solh M, Jamani K, Lehmann L, Savani B, Schultz KR, Wirk BM, Spellman S, Arora M, Pidala J. Khoury HJ, et al. Among authors: jamani k. Haematologica. 2017 May;102(5):958-966. doi: 10.3324/haematol.2016.156356. Epub 2017 Mar 16. Haematologica. 2017. PMID: 28302712 Free PMC article.
Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients.
Jamani K, Onstad LE, Bar M, Carpenter PA, Krakow EF, Salit RB, Flowers MED, Lee SJ. Jamani K, et al. Biol Blood Marrow Transplant. 2018 Nov;24(11):2271-2276. doi: 10.1016/j.bbmt.2018.06.015. Epub 2018 Jun 21. Biol Blood Marrow Transplant. 2018. PMID: 29935213 Free PMC article.
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
Evernden C, Dowhan M, Dabas R, Chaudhry A, Kalra A, Dharmani-Khan P, Gregson D, Johnson A, Jupp J, Jimenez-Zepeda V, Jamani K, Duggan P, Tay J, Khan F, Daly A, Storek J. Evernden C, et al. Among authors: jamani k. Cytotherapy. 2020 Jan;22(1):27-34. doi: 10.1016/j.jcyt.2019.11.002. Epub 2019 Dec 27. Cytotherapy. 2020. PMID: 31889628
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulin.
Ousia S, Kalra A, Williamson TS, Prokopishyn N, Dharmani-Khan P, Khan FM, Jimenez-Zepeda V, Jamani K, Duggan PR, Daly A, Russell JA, Storek J. Ousia S, et al. Among authors: jamani k. Clin Transplant. 2020 Sep;34(9):e14018. doi: 10.1111/ctr.14018. Epub 2020 Jul 4. Clin Transplant. 2020. PMID: 32573834
Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases.
Shifa I, Hazlewood GS, Durand C, Barr SG, Mydlarski PR, Beck PL, Burton JM, Khan FM, Jamani K, Osman M, Storek J. Shifa I, et al. Among authors: jamani k. Transplant Cell Ther. 2021 Jun;27(6):489.e1-489.e9. doi: 10.1016/j.jtct.2021.03.023. Epub 2021 Mar 26. Transplant Cell Ther. 2021. PMID: 33775907 Free article.
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.
Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw B. Bhatt NS, et al. Among authors: jamani k. Transplant Cell Ther. 2021 Aug;27(8):679.e1-679.e8. doi: 10.1016/j.jtct.2021.04.013. Epub 2021 Apr 22. Transplant Cell Ther. 2021. PMID: 33895402 Free PMC article.
Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation.
Kinzel M, Dowhan M, Kalra A, Williamson TS, Dabas R, Jamani K, Chaudhry A, Shafey M, Jimenez-Zepeda V, Duggan P, Daly A, Dharmani-Khan P, Khan F, Storek J. Kinzel M, et al. Among authors: jamani k. Transplant Cell Ther. 2022 Jan;28(1):53.e1-53.e10. doi: 10.1016/j.jtct.2021.09.021. Epub 2021 Oct 1. Transplant Cell Ther. 2022. PMID: 34607072 Free article.
56 results